MB Diagnostics ApS: Financial statements 2024
CVR: 38185853
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
MB Diagnostics ApS (CVR 38185853) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -2,275 and a net result of DKK -15,293 compared with DKK 9,905 the year before. Equity in the 2024 report amounted to DKK 589,656. The solvency ratio was 55.1%.
- Gross Profit
- DKK -2,275
- Profit/Loss
- DKK -15,293
- Equity
- DKK 589,656
- Total Assets
- DKK 1,069,942
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -2 t. | -15 t. | 590 t. | 0 |
| 2023 | - | 30 t. | 10 t. | 605 t. | 0 |
| 2022 | - | 15 t. | -2 t. | 713 t. | 0 |
| 2021 | - | 43 t. | 22 t. | 828 t. | 0 |
| 2020 | - | -9 t. | -20 t. | 807 t. | 0 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
MB Diagnostics ApS has published its annual report for 2023. Gross profit came to DKK 30,014, and the net result was DKK 9,905.
About MB Diagnostics ApS
MB Diagnostics ApS is a Danish company of the type Anpartsselskab based in Nærum, founded in 2016. The company is registered under the industry Fremstilling af bestrålingsudstyr og elektromedicinsk og elektroterapeutisk udstyr. The management consists of Mikael Ploug Boesen. The company is owned by Mikael Ploug Boesen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -11,000 and a net result of DKK -23,026 compared with DKK -15,293 the year before. Equity in the 2025 report amounted to DKK 566,629.